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Introduction
Current available reports about the prognostic value of
dobutamine stress cardiovascular magnetic resonance
(DCMR) are limited by the number of patients and car-
diac events.
Purpose
Aim of this study was to assess the long-term value of
DCMR for prediction of late cardiac events in a large
cohort of patients with known or suspected coronary
artery disease.
Methods
Clinical data and DCMR results were analyzed in 1466
consecutive patients undergoing DCMR between 2000
and 2004. Ninety four patients lost to follow-up and three
hundred fifty five patients who underwent early revascu-
larization within 3 months of DCMR were excluded from
analysis. The remaining 1017 patients (median age, 62
years) were followed up for a mean of 44 ± 24 months
(range: 1 to 116 months). Wall motion abnormalities
(WMA) at rest and the presence of stress-induced WMA
(ischemia) were assessed for each patient. Cardiac events,
defined as cardiac death and non-fatal myocardial infarc-
tion, were related to clinical and DCMR results. Patients
with inducible WMA were compared in regards to follow-
ing therapy (revascularization or medical therapy alone)
and outcome.
Results
Twenty nine percent of the patients experienced an induc-
ible WMA during testing. Forty six cardiac events were
reported, documented cardiac death in 33 and nonfatal
myocardial infarction in 13 patients. In those with and
without inducible WMA, the proportion of patients with
cardiac events were 8.0% versus 3.1%, respectively, (haz-
ard ratio: 3.3; 95% confidence interval: 1.8 to 5.9 for the
presence of inducible WMA; p < 0.001). A normal DCMR
carried a relatively good prognosis, with a 5-year event-
free survival of 97.1%.
Patients who underwent revascularization within 3
months of DCMR due to inducible WMA demonstrated a
significant lower rate of cardiac events (5.1%) compared
to patients with inducible WMA and medical therapy only
(8.0%), p < 0.001.
Conclusion
In a large cohort of patients, DCMR has an added value for
predicting cardiac events during long-term follow-up,
improving the differentiation between high-risk and low-
risk patients. Patients with inducible WMA and following
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